Group items tagged News - medindia

Boehringer's Pradaxa gets FDA approval for DVT, PE treatment - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...vt-pe-treatment-090414-4211375

health news medical pharma

shared by Alex Parker on 09 Apr 14 - No Cached

Alex Parker on 09 Apr 14

Germany-based pharmaceutical firm Boehringer Ingelheim has received approval from the US Food and Drug Administration (FDA) for Pradaxa (dabigatran etexilate) to treat venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE).

<div class="cArrow"> </div><div class="cContentInner">Germany-based pharmaceutical firm Boehringer Ingelheim has received approval from the US Food and Drug Administration (FDA) for Pradaxa (dabigatran etexilate) to treat venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE).</div>

...

Cancel

Tetraphase's eravacycline gets FDA fast track status - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...st-track-status-030414-4208894

health news medical pharma

shared by Alex Parker on 04 Apr 14 - No Cached

Alex Parker on 04 Apr 14

The US Food & Drug Administration (FDA) has granted fast track designations for both the intravenous (IV) and oral formulations of Tetraphase Pharmaceuticals' lead antibiotic candidate, eravacycline.

<div class="cArrow"> </div><div class="cContentInner">The US Food & Drug Administration (FDA) has granted fast track designations for both the intravenous (IV) and oral formulations of Tetraphase Pharmaceuticals' lead antibiotic candidate, eravacycline.</div>

...

Cancel

Dainippon's Latuda gets approval in Canada to treat bipolar depression - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...olar-depression-040414-4209058

health news medical pharma

shared by Alex Parker on 04 Apr 14 - No Cached

Alex Parker on 04 Apr 14

Dainippon Sumitomo Pharma (DSP) has received approval from Health Canada for use of Latuda (lurasidone HCl) as monotherapy or as adjunctive therapy with lithium or valproate to treat depressive episodes associated with bipolar I disorder.

<div class="cArrow"> </div><div class="cContentInner">Dainippon Sumitomo Pharma (DSP) has received approval from Health Canada for use of Latuda (lurasidone HCl) as monotherapy or as adjunctive therapy with lithium or valproate to treat depressive episodes associated with bipolar I disorder.</div>

...

Cancel

PanOptica raises $45m to finance clinical development of anti-VEGF eye drop for wet AMD - 1 views

manufacturing.pharmaceutical-business-review.com/...rop-for-wet-amd-160414-4215489

health news medical pharma

shared by Alex Parker on 16 Apr 14 - No Cached

Alex Parker on 16 Apr 14

PanOptica has raised up to $45m in a Series B financing to fund the clinical program for its lead compound, PAN-90806, a pharmacologically unique small-molecule selective inhibitor of VEGF

<div class="cArrow"> </div><div class="cContentInner">PanOptica has raised up to $45m in a Series B financing to fund the clinical program for its lead compound, PAN-90806, a pharmacologically unique small-molecule selective inhibitor of VEGF</div>

...

Cancel

GlaxoSmithKline's Tanzeum gets FDA approval for type 2 diabetes treatment - 1 views

drugdelivery.pharmaceutical-business-review.com/...betes-treatment-160414-4215125

health news medical pharma

shared by Alex Parker on 16 Apr 14 - No Cached

Alex Parker on 16 Apr 14

GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.

<div class="cArrow"> </div><div class="cContentInner">GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.</div>

...

Cancel

Charles River acquires Galapagos' CRO services division - 1 views

contractresearch.pharmaceutical-business-review.com/...rvices-division-010414-4207101

health news medical pharma

shared by Alex Parker on 02 Apr 14 - No Cached

Alex Parker on 02 Apr 14

Charles River Laboratories International (CRL) has completed the previously announced acquisition of the CRO services division of Galapagos (GLPGF), which includes both Argenta and BioFocus.

<div class="cArrow"> </div><div class="cContentInner">Charles River Laboratories International (CRL) has completed the previously announced acquisition of the CRO services division of Galapagos (GLPGF), which includes both Argenta and BioFocus.</div>

...

Cancel

Valeant, Ackman sign deal to acquire Botox-maker Allergan for $45bn - 1 views

manufacturing.pharmaceutical-business-review.com/...lergan-for-45bn-230414-4218796

health news medical pharma

shared by Alex Parker on 23 Apr 14 - No Cached

Alex Parker on 23 Apr 14

PBR Staff Writer Published 23 April 2014 Canada-based Valeant Pharmaceuticals (Valeant) and activist investor Bill Ackman have revealed details of their offer to acquire Botox-maker Allergan, in a cash-and-stock deal that could be worth more than $45bn. Under the deal, Allergan investors would receive $48.30 in cash and 0.83 of a Valeant stock for each share they own.

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 23 April 2014 Canada-based Valeant Pharmaceuticals (Valeant) and activist investor Bill Ackman have revealed details of their offer to acquire Botox-maker Allergan, in a cash-and-stock deal that could be worth more than $45bn. Under the deal, Allergan investors would receive $48.30 in cash and 0.83 of a Valeant stock for each share they own.</div>

...

Cancel

Novartis reshapes business by signing deals with GSK, Eli Lilly - 2 views

manufacturing.pharmaceutical-business-review.com/...h-gsk-eli-lilly-220414-4218360

health news medical pharma daily

shared by Alex Parker on 23 Apr 14 - No Cached

Alex Parker on 23 Apr 14

PBR Staff Writer Published 22 April 2014 Swiss pharmaceutical firm Novartis has entered into a definitive agreement to acquire the oncology unit of Britain's GlaxoSmithKline (GSK) for about $14.5bn and up to $1.5bn contingent on a development milestone. As part of the deal, Novartis would have opt-in rights to GSK's current and future oncology R&D pipeline.

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 22 April 2014 Swiss pharmaceutical firm Novartis has entered into a definitive agreement to acquire the oncology unit of Britain's GlaxoSmithKline (GSK) for about $14.5bn and up to $1.5bn contingent on a development milestone. As part of the deal, Novartis would have opt-in rights to GSK's current and future oncology R&D pipeline.</div>

...

Cancel

FDA approves GSK's Incruse Ellipta to treat airflow obstruction in COPD patients - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...n-copd-patients-010514-4256177

health news medical pharma daily

shared by Alex Parker on 01 May 14 - No Cached

Alex Parker on 01 May 14

PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.</div>

...

Cancel

ACETO completes acquisition of PACK Pharmaceuticals - 1 views

otc.pharmaceutical-business-review.com/...pharmaceuticals-010514-4256158

health news medical pharma

shared by Alex Parker on 01 May 14 - No Cached

Alex Parker on 01 May 14

Published 01 May 2014 ACETO has announced that its wholly-owned subsidiary, Rising Pharmaceutical, has closed the acquisition of 100% of the equity interests of PACK Pharmaceuticals, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products. The total transaction value is approximately $100m.

<div class="cArrow"> </div><div class="cContentInner">Published 01 May 2014 ACETO has announced that its wholly-owned subsidiary, Rising Pharmaceutical, has closed the acquisition of 100% of the equity interests of PACK Pharmaceuticals, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products. The total transaction value is approximately $100m.</div>

...

Cancel

MabVax Therapeutics and Telik sign definitive merger agreement - 1 views

drugdiscovery.pharmaceutical-business-review.com/...erger-agreement-130514-4265439

health news medical pharma daily

shared by Alex Parker on 13 May 14 - No Cached

Alex Parker on 13 May 14

MabVax Therapeutics and Telik sign definitive merger agreement

<div class="cArrow"> </div><div class="cContentInner">MabVax Therapeutics and Telik sign definitive merger agreement</div>

...

Cancel

FDA approves Xolair for treatment of chronic hives - 1 views

Physical Activity Reduces Mortality in People With Metabolic Syndrome | MedIndia - 0 views

med india on 11 Oct 11

Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.

<div class="cArrow"> </div><div class="cContentInner">Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.</div>

...

Cancel

World Standards Day 2011 - Q&A on Healthcare Standards in India Read more: World Stand... - 0 views

shared by med india on 13 Oct 11 - No Cached

med india on 13 Oct 11

UK doctors are still undertreating one of the major risk factors for stroke - atrial fibrillation shows recent study published in BMJ Open.

<div class="cArrow"> </div><div class="cContentInner">UK doctors are still undertreating one of the major risk factors for stroke - atrial fibrillation shows recent study published in BMJ Open.</div>

...

Cancel

Hormonal Contraceptive Pills Affect Sexual Life | MedIndia - 0 views

med india on 01 Nov 11

Hormonal contraceptive pills have been found to dampen a woman's sexual life by interfering with arousal, lubrication, sexual desire and orgasm.

<div class="cArrow"> </div><div class="cContentInner">Hormonal contraceptive pills have been found to dampen a woman's sexual life by interfering with arousal, lubrication, sexual desire and orgasm.</div>

...

Cancel

Healthy Childhood Diet may Lower Chronic Disease Risk | MedIndia - 0 views

med india on 01 Nov 11

Childhood diet lower in fat and higher in fiber content can decrease risk for chronic diseases such as diabetes and heart disease in adulthood, shows study.

<div class="cArrow"> </div><div class="cContentInner">Childhood diet lower in fat and higher in fiber content can decrease risk for chronic diseases such as diabetes and heart disease in adulthood, shows study.</div>

...

Cancel

Happiness Linked With Longevity | MedIndia - 0 views

www.medindia.net/...ked-With-Longevity-92765-1.htm

live longer survival happiness lifestyle emotions well-being daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 01 Nov 11 - No Cached

med india on 01 Nov 11

People who are happy are 35% less likely to die early.

<div class="cArrow"> </div><div class="cContentInner">People who are happy are 35% less likely to die early.</div>

...

Cancel

Snakes Can Give Really Useful Advice on Heart Health | MedIndia - 0 views

www.medindia.net/...ce-on-Heart-Health-92614-1.htm

Science health US animal heart daily news for the day dental pharma medical breakthroughs topic

shared by med india on 29 Oct 11 - No Cached

med india on 29 Oct 11

Snakes get a bad rap for being slimy, cold-hearted creatures, but US researchers said Thursday some actually have huge hearts that could offer clues to treating people with cardiac disease.

<div class="cArrow"> </div><div class="cContentInner">Snakes get a bad rap for being slimy, cold-hearted creatures, but US researchers said Thursday some actually have huge hearts that could offer clues to treating people with cardiac disease.</div>

...

Cancel

Rich Brit Students Blamed for Binge Drinking Culture | MedIndia - 0 views

www.medindia.net/...e-Drinking-Culture-92692-1.htm

binge drinking Brit students daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 31 Oct 11 - No Cached

med india on 31 Oct 11

British university students may have begun the binge drinking culture in England, a study reveals.

<div class="cArrow"> </div><div class="cContentInner">British university students may have begun the binge drinking culture in England, a study reveals.</div>

...

Cancel

Prostate Cancer Diagnosis Has Not Deterred Larry Hagman From Working | MedIndia - 0 views

www.medindia.net/...agman-From-Working-92691-1.htm

Prostate cancer Larry Hagman daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 31 Oct 11 - No Cached

med india on 31 Oct 11

Brave heart Larry Hagman has vowed to keep on working despite battling prostate cancer.

<div class="cArrow"> </div><div class="cContentInner">Brave heart Larry Hagman has vowed to keep on working despite battling prostate cancer.</div>

...

Cancel

Group items tagged

Boehringer's Pradaxa gets FDA approval for DVT, PE treatment - 1 views

Tetraphase's eravacycline gets FDA fast track status - 1 views

Dainippon's Latuda gets approval in Canada to treat bipolar depression - 1 views

PanOptica raises $45m to finance clinical development of anti-VEGF eye drop for wet AMD - 1 views

GlaxoSmithKline's Tanzeum gets FDA approval for type 2 diabetes treatment - 1 views

Charles River acquires Galapagos' CRO services division - 1 views

Valeant, Ackman sign deal to acquire Botox-maker Allergan for $45bn - 1 views

Novartis reshapes business by signing deals with GSK, Eli Lilly - 2 views

FDA approves GSK's Incruse Ellipta to treat airflow obstruction in COPD patients - 1 views

ACETO completes acquisition of PACK Pharmaceuticals - 1 views

MabVax Therapeutics and Telik sign definitive merger agreement - 1 views

FDA approves Xolair for treatment of chronic hives - 1 views

Physical Activity Reduces Mortality in People With Metabolic Syndrome | MedIndia - 0 views

World Standards Day 2011 - Q&A on Healthcare Standards in India Read more: World Stand... - 0 views

Hormonal Contraceptive Pills Affect Sexual Life | MedIndia - 0 views

Healthy Childhood Diet may Lower Chronic Disease Risk | MedIndia - 0 views

Happiness Linked With Longevity | MedIndia - 0 views

Snakes Can Give Really Useful Advice on Heart Health | MedIndia - 0 views

Rich Brit Students Blamed for Binge Drinking Culture | MedIndia - 0 views

Prostate Cancer Diagnosis Has Not Deterred Larry Hagman From Working | MedIndia - 0 views

Related searches